IP Library Granted Patent US 8,618,222
Granted Patent B2
US 8,618,222 · App. 13/417,389 · Granted Dec 31, 2013

Curable fluoroelastomer composition

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,618,222
App. No.
13/417,389
Granted
Dec 31, 2013
Kind
B2
Abstract

Fluoroelastomer compositions comprising fluoroelastomers having copolymerized units of a nitrile group-containing cure site monomer are cured with certain hydroxylamine derivatives. The hydroxylamine derivative is of formula R 1 (C(O)) n NHOR 2 wherein n is 0 or 1; R 1 is H, C(O)R 3 , C(O)R 4 , C(O)OR 3 , or C(O)SR 3 ; R 2 is H, C(O)R 3 , or C(O)OR 3 ; R 3 is C 1 -C 20 alkyl group, aryl, heterocycle, benzyl, 9-fluorenylmethyl, or CH 2 R 4 ; and R 4 is a fluoroalkyl group, with the proviso that R 1 and R 2 cannot simultaneously be H.

Claims (12)

1. A curable composition comprising:

A. a fluoroelastomer comprising copolymerized units of a nitrile group-containing cure site monomer; and

B. an hydroxylamine derivative of formula R 1 (C(O)) n NHOR 2 wherein n is 0 or 1; R 1 is H, C(O)R 3 , C(O)R 4 , C(O)OR 3 , or C(O)SR 3 ; R 2 is H, C(O)R 3 , or C(O)OR 3 ; R 3 is C 1 -C 20 alkyl group, aryl, heterocycle, benzyl, 9-fluorenylmethyl, or CH 2 R 4 ; and R 4 is a fluoroalkyl group, with the proviso that R 1 and R 2 cannot simultaneously be H.

2. A curable composition of claim 1 wherein n is 0; R 1 is H and R 2 is C(O)R 3 .

3. A curable composition of claim 1 wherein n is 0; R 1 is H and R 2 is C(O)OR 3 .

4. A curable composition of claim 1 wherein n is 0; R 1 is C(O)R 3 and R 2 is H.

5. A curable composition of claim 1 wherein n is 0; R 1 is C(O)R 4 and R 2 is H.

6. A curable composition of claim 1 wherein n is 0; R 1 is C(O)R 3 and R 2 is C(O)OR 3 .

7. A curable composition of claim 1 wherein n is 0; R 1 is C(O)OR 3 and R 2 is C(O)OR 3 .

8. A curable composition of claim 1 wherein the hydroxylamine derivative is selected from the group consisting of acetohydroxamic acid, benzyl-N-hydroxycarbamate, tert-butyl N-hydroxycarbamate, benzohydroxamic acid, N,O-(tert-butoxycarbonyl)hydroxylamine, succinohydroxamic acid, and benzoyloxyamine hydrochloride.

9. A curable composition of claim 1 further comprising a curative accelerator.

10. A cured article formed from the composition of claim 1 .

Assignments (7)
NUNC PRO TUNC ASSIGNMENT Recorded Nov 6, 2025
From: DUPONT POLYMERS, INC.
To: DUPONT SPECIALTY PRODUCTS USA, LLC
Reel/Frame 072805/0695 →
SECURITY INTEREST Recorded Nov 3, 2025
From: QNITY ELECTRONICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 073515/0243 →
SECURITY INTEREST Recorded Nov 3, 2025
From: QNITY ELECTRONICS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT
Reel/Frame 073517/0298 →
NUNC PRO TUNC ASSIGNMENT Recorded Sep 6, 2024
From: DUPONT POLYMERS, INC.
To: DUPONT POLYMERS, INC.
Reel/Frame 068512/0400 →
CHANGE OF ADDRESS Recorded Sep 6, 2024
From: DUPONT POLYMERS, INC.
To: DUPONT POLYMERS, INC.
Reel/Frame 068859/0287 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT POLYMERS, INC.
Reel/Frame 049587/0098 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2012
From: BISH, CHRISTOPHER J.; MORKEN, PETER A.
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 027968/0220 →